ArticlePloS one2020

Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.

Noriyuki Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.